Denise Bohrer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Denise Bohrer has a total of 113 co-authors. Here are the top co-authors by number of shared publications:
- Leandro Machado de Carvalho
Graduate Program in Chemistry, Department of Chemistry, Federal University of Santa Maria, PO Box 5051, 97105-970, Santa Maria, RS, Brazil
12 shared publications Paulo Cícero Do Nascimento
Department of Chemistry, Federal University of Santa Maria, Av. Roraima, Santa Maria, Brazil; and
11 shared publications- Solange Cristina Garcia
Universidade Federal do Rio Grande do Sul
8 shared publications - Carine Viana
Graduate Program in Pharmaceutical Sciences, Federal University of Santa Maria (UFSM), Santa Maria-RS, Brazil
7 shared publications - Emilene Becker
Institut of Chemistry, Federal University of Rio Grande do Sul, AC Campus da UFRGS, Agronomia 91501-970 Porto Alegre,Brazil
6 shared publications Leandro Machado de Carvalho
Departamento de Química, Universidade Federal de Santa Maria, Santa Maria, RS, Brazil
6 shared publications
Latest Publications
- 1 January 2021
- Published by Elsevier in Current Pharmaceutical Analysis
- Vol. 17 (1) , 129-139
Assessment of Purity Parameters of Generic and Brand Name Losartan Potassium
Background: Generic products must be bioequivalent to the innovator brand product. Nevertheless, in addition to meeting bioequivalence standards, attention must be paid to the content of the active substance and contaminants in generic drugs. Objective: This study compared the pharmaceutical quality of four generic losartan potassium formulations with the brand-name product: Cozaar®. Methods: The United States Pharmacopeia (USP) losartan potassium standard was used as reference material. The products tested (all 50 mg formulations) included four generic tablet formulations and the innovator brand product Cozaar®. Active substance content, organic impurities, and elemental impurities were assessed following the USP monograph for losartan potassium tablets and USP Chapter on Elemental Impurities. Results: The results showed that three of the four generic products had low content of the active ingredient. The values ranged from 86.4 to 93.8%, being acceptable not below 95% of the labeled amount. Organic impurities were not detected in any of the products, and of the 13 elemental impurities tested, only four elements were detected. The elemental impurities Cr, Ni, Cu, and As were, however, in amounts within the limits established by the USP monograph. The only concern on the generic drugs analyzed was the low content of the active ingredient in 75% of the products. Conclusion: Since losartan is a drug of continuous use, lower content of the active ingredient may go unnoticed by the users of the generic product and entailed clinical consequences during long-term therapy.
- 1 January 2021
- Published by Elsevier in Current Pharmaceutical Analysis
- Vol. 17 (1) , 129-139
Assessment of Purity Parameters of Generic and Brand Name Losartan Potassium
Background: Generic products must be bioequivalent to the innovator brand product. Nevertheless, in addition to meeting bioequivalence standards, attention must be paid to the content of the active substance and contaminants in generic drugs. Objective: This study compared the pharmaceutical quality of four generic losartan potassium formulations with the brand-name product: Cozaar®. Methods: The United States Pharmacopeia (USP) losartan potassium standard was used as reference material. The products tested (all 50 mg formulations) included four generic tablet formulations and the innovator brand product Cozaar®. Active substance content, organic impurities, and elemental impurities were assessed following the USP monograph for losartan potassium tablets and USP Chapter on Elemental Impurities. Results: The results showed that three of the four generic products had low content of the active ingredient. The values ranged from 86.4 to 93.8%, being acceptable not below 95% of the labeled amount. Organic impurities were not detected in any of the products, and of the 13 elemental impurities tested, only four elements were detected. The elemental impurities Cr, Ni, Cu, and As were, however, in amounts within the limits established by the USP monograph. The only concern on the generic drugs analyzed was the low content of the active ingredient in 75% of the products. Conclusion: Since losartan is a drug of continuous use, lower content of the active ingredient may go unnoticed by the users of the generic product and entailed clinical consequences during long-term therapy.
- 8 December 2018
- Published by International Pharmaceutical Excipients Council of the Americas in International Journal of Pharmaceutical Excipients
- Vol. 9 (4)
An improved method for the assay of TiO2 purity and its determination in drugs using flame atomic absorption spectrometry.
A quantitative method for determining TiO2 was developed. The proposed method is based on analysis by flame atomic absorption spectrometry (FAAS) and presents advantages over the current pharmacopeial monographs for TiO2 assay by dispensing the use of mercury for sample pretreatment. Solid drugs (tablets and capsules) and TiO2 were decomposed by a mixture of sulfuric acid/ammonium sulfate, diluted, and analyzed by FAAS. The method was validated according to the USP Validation of Compendia Procedure and the USP Atomic Absorption Spectroscopy monograph. All parameters were in accordance with the compendium criteria. Analysis of a TiO2 powder standard sample, which showed purity (99.5%) within the established limits, confirms the adequacy of the proposed method. Six samples were analyzed following the proposed method and consisted of three TiO2 samples from different suppliers and three different drugs, Cozaar (Merck) and Zocor (Merck) tablets, and Peprazol (Libbs) capsules, which were expected to contain TiO2 as an ingredient. The purity of the assayed TiO2 samples ranged from 79.2% to 90.5%, and the amount of TiO2 in the drugs from 2.8 to 3.8 mg/g.
- 8 December 2018
- Published by International Pharmaceutical Excipients Council of the Americas in International Journal of Pharmaceutical Excipients
- Vol. 9 (4)
An improved method for the assay of TiO2 purity and its determination in drugs using flame atomic absorption spectrometry.
A quantitative method for determining TiO2 was developed. The proposed method is based on analysis by flame atomic absorption spectrometry (FAAS) and presents advantages over the current pharmacopeial monographs for TiO2 assay by dispensing the use of mercury for sample pretreatment. Solid drugs (tablets and capsules) and TiO2 were decomposed by a mixture of sulfuric acid/ammonium sulfate, diluted, and analyzed by FAAS. The method was validated according to the USP Validation of Compendia Procedure and the USP Atomic Absorption Spectroscopy monograph. All parameters were in accordance with the compendium criteria. Analysis of a TiO2 powder standard sample, which showed purity (99.5%) within the established limits, confirms the adequacy of the proposed method. Six samples were analyzed following the proposed method and consisted of three TiO2 samples from different suppliers and three different drugs, Cozaar (Merck) and Zocor (Merck) tablets, and Peprazol (Libbs) capsules, which were expected to contain TiO2 as an ingredient. The purity of the assayed TiO2 samples ranged from 79.2% to 90.5%, and the amount of TiO2 in the drugs from 2.8 to 3.8 mg/g.
- 19 September 2018
- Published by Parenteral Drug Association, Inc. in PDA Journal of Pharmaceutical Science and Technology
- Vol. 73 (1) , 60-69
Extraction/Leaching of Metal-Containing Additives from Polyvinyl Chloride, Ethyl Vinyl Acetate, and Polypropylene Bags and Infusion Sets into Infusion Solutions
Flexible medical devices are primarily made of plasticized polyvinyl chloride (PVC). Lately, PVC is being replaced with ethyl vinyl acetate (EVA) and polypropylene (PP) to avoid undesired migration of the PVC plasticizers. Nevertheless, other additives are necessary to generate useful polymeric materials. Metallic species present in such additives can also leach out into the infusion solutions. The migration of Ba, Cd, Sn, Pb, and Zn from devices made from PVC, EVA, and PP was evaluated. Bags and infusion sets were decomposed, and their metallic contents were analyzed. Glucose, NaCl, and Tween 80 were investigated as extraction media. These solutions were stored in PVC, EVA, and PP bags, heat sterilized, and stored for eight months at room temperature. Aliquots were taken before and after sterilization and then once per month to determine the contents of the metals. Commercial glucose and NaCl infusions were analyzed by taking aliquots of the solutions from the bags and from the administration set after their administration to patients. The three polymers contained the five metals. Ba was found in the highest concentration in all samples, with a mean of 8.0 mg/kg in PVC, 4.2 mg/kg in EVA, and 4.7 mg/kg in PP samples. Despite this, the only element that migrated into the glucose, NaCl, and Tween 80 solutions was Zn. The same result was found for the commercial glucose and NaCl infusions. Moreover, the Zn concentration in the administration sets was on average 52% higher than what was found in the bags.
- 19 September 2018
- Published by Parenteral Drug Association, Inc. in PDA Journal of Pharmaceutical Science and Technology
- Vol. 73 (1) , 60-69
Extraction/Leaching of Metal-Containing Additives from Polyvinyl Chloride, Ethyl Vinyl Acetate, and Polypropylene Bags and Infusion Sets into Infusion Solutions
Flexible medical devices are primarily made of plasticized polyvinyl chloride (PVC). Lately, PVC is being replaced with ethyl vinyl acetate (EVA) and polypropylene (PP) to avoid undesired migration of the PVC plasticizers. Nevertheless, other additives are necessary to generate useful polymeric materials. Metallic species present in such additives can also leach out into the infusion solutions. The migration of Ba, Cd, Sn, Pb, and Zn from devices made from PVC, EVA, and PP was evaluated. Bags and infusion sets were decomposed, and their metallic contents were analyzed. Glucose, NaCl, and Tween 80 were investigated as extraction media. These solutions were stored in PVC, EVA, and PP bags, heat sterilized, and stored for eight months at room temperature. Aliquots were taken before and after sterilization and then once per month to determine the contents of the metals. Commercial glucose and NaCl infusions were analyzed by taking aliquots of the solutions from the bags and from the administration set after their administration to patients. The three polymers contained the five metals. Ba was found in the highest concentration in all samples, with a mean of 8.0 mg/kg in PVC, 4.2 mg/kg in EVA, and 4.7 mg/kg in PP samples. Despite this, the only element that migrated into the glucose, NaCl, and Tween 80 solutions was Zn. The same result was found for the commercial glucose and NaCl infusions. Moreover, the Zn concentration in the administration sets was on average 52% higher than what was found in the bags.
- 1 May 2017
- Published by Oxford University Press (OUP)
- Vol. 100 (3) , 737-743
Determination of Antimony in Pharmaceutical Formulations and Beverages Using High-Resolution Continuum-Source Graphite Furnace Atomic Absorption Spectrometry
A sensitive and accurate method, employing high-resolutioncontinuum source atomic absorption spectrometry, for the determination of antimony (Sb) was developed. Conditions such as pyrolysis and atomization temperatures, the use of chemical modifiers, and sample pretreatment were optimized for the determination of Sb in pharmaceutical preparations and beverages stored in polyethylene terephthalate (PET) containers. In addition to container analysis, the influence of time of contact, temperature, and content composition on the migration of Sbwas investigated. Twenty-six samples were periodically analyzed until finalize 1 year bottling. Eight mineral water samples were analyzed after storage at temperatures from 40 to 80°C for 48 h. Five different-colored PET samples were stored at 80°C for 20 days and periodically analyzed. Bottles, containing from 46.4 mg/kg Sb (amber PET) to 91.6 mg/kgSb (colorless PET), leached Sb depending on the content ingredients, time of contact, and temperature. Although drinking water itself did not promote Sb migration at room temperature,juices and medicines did. After 1 year of storage, the Sb level in the samples ranged from 5 to 50 μg/L. The rate of leaching depended on the temperature, which was slow below 60°C, but rapidly increased at 60–80°C. The higher the Sb content in the bottle, the higher the amount of migration. Because Sb is a possible carcinogen to humans, containers for pharmaceutical use should be better controlled, and factors that increase Sb leaching in products that are widely consumed should be avoided.
- 1 May 2017
- Published by Oxford University Press (OUP)
- Vol. 100 (3) , 737-743
Determination of Antimony in Pharmaceutical Formulations and Beverages Using High-Resolution Continuum-Source Graphite Furnace Atomic Absorption Spectrometry
A sensitive and accurate method, employing high-resolutioncontinuum source atomic absorption spectrometry, for the determination of antimony (Sb) was developed. Conditions such as pyrolysis and atomization temperatures, the use of chemical modifiers, and sample pretreatment were optimized for the determination of Sb in pharmaceutical preparations and beverages stored in polyethylene terephthalate (PET) containers. In addition to container analysis, the influence of time of contact, temperature, and content composition on the migration of Sbwas investigated. Twenty-six samples were periodically analyzed until finalize 1 year bottling. Eight mineral water samples were analyzed after storage at temperatures from 40 to 80°C for 48 h. Five different-colored PET samples were stored at 80°C for 20 days and periodically analyzed. Bottles, containing from 46.4 mg/kg Sb (amber PET) to 91.6 mg/kgSb (colorless PET), leached Sb depending on the content ingredients, time of contact, and temperature. Although drinking water itself did not promote Sb migration at room temperature,juices and medicines did. After 1 year of storage, the Sb level in the samples ranged from 5 to 50 μg/L. The rate of leaching depended on the temperature, which was slow below 60°C, but rapidly increased at 60–80°C. The higher the Sb content in the bottle, the higher the amount of migration. Because Sb is a possible carcinogen to humans, containers for pharmaceutical use should be better controlled, and factors that increase Sb leaching in products that are widely consumed should be avoided.
- 1 January 2017
- Published by Oxford University Press (OUP) in Journal of AOAC INTERNATIONAL
Determination of Polycyclic Aromatic Hydrocarbons in Commercial Parenteral Formulations and Medications Using High-Performance Liquid Chromatography with Diode Array Detection
HPLC coupled to UV diode array detection (DAD) is proposed for the determination of polycyclic aromatic hydrocarbons (PAHs) in pharmaceutical products for parenteral administration. Because rubber is a possible source of PAHs for these products, samples stored in containers with rubber parts were selected for the analysis. The basis for method optimization was EPA Method 8310, which determines 16 priority PAHs in ground water and wastewater by HPLC using both UV and fluorescence detection. Using DAD, two channels were selected for detection, with one operating at 254 nm for the detection of nine PAHs and the other at 225 nm for the detection of seven PAHs. This method allowed for the detection of PAHs using external calibration with LODs and LOQs ranging from 0.001 to 0.060 μg/mL and from 0.003 to 0.167 μg/mL, respectively. Within-day precision, expressed as RSD, varied from 1.24 to 7.76% for PAH concentrations from 0.05 to 0.50 μg/mL, and intraday precision varied from 3.10 to 9.40% for the same concentration range. Method accuracy was confirmed by recoveries of 75120% of the spiked samples. This method was applied for the determination of PAHs in three commercial infusion solutions and in nine different medications stored in syringes prior to administration to patients. Twelve of 16 PAHs were found in these samples. Total PAH concentrations varied from 0.13 to 13.50 μg/mL. Pyrene was the most prevalent contaminant, being present in 11 of 12 samples in concentrations ranging from 0.17 to 4.80 μg/mL. This method presented good sensitivity for the measurement of PAH in the target samples, allowing for the determination of the 16 priority PAHs in one run and in 30 min.
- 1 January 2017
- Published by Oxford University Press (OUP) in Journal of AOAC INTERNATIONAL
Determination of Polycyclic Aromatic Hydrocarbons in Commercial Parenteral Formulations and Medications Using High-Performance Liquid Chromatography with Diode Array Detection
HPLC coupled to UV diode array detection (DAD) is proposed for the determination of polycyclic aromatic hydrocarbons (PAHs) in pharmaceutical products for parenteral administration. Because rubber is a possible source of PAHs for these products, samples stored in containers with rubber parts were selected for the analysis. The basis for method optimization was EPA Method 8310, which determines 16 priority PAHs in ground water and wastewater by HPLC using both UV and fluorescence detection. Using DAD, two channels were selected for detection, with one operating at 254 nm for the detection of nine PAHs and the other at 225 nm for the detection of seven PAHs. This method allowed for the detection of PAHs using external calibration with LODs and LOQs ranging from 0.001 to 0.060 μg/mL and from 0.003 to 0.167 μg/mL, respectively. Within-day precision, expressed as RSD, varied from 1.24 to 7.76% for PAH concentrations from 0.05 to 0.50 μg/mL, and intraday precision varied from 3.10 to 9.40% for the same concentration range. Method accuracy was confirmed by recoveries of 75120% of the spiked samples. This method was applied for the determination of PAHs in three commercial infusion solutions and in nine different medications stored in syringes prior to administration to patients. Twelve of 16 PAHs were found in these samples. Total PAH concentrations varied from 0.13 to 13.50 μg/mL. Pyrene was the most prevalent contaminant, being present in 11 of 12 samples in concentrations ranging from 0.17 to 4.80 μg/mL. This method presented good sensitivity for the measurement of PAH in the target samples, allowing for the determination of the 16 priority PAHs in one run and in 30 min.